Experimental Therapy of Advanced Breast Cancer: Targeting NFAT1-MDM2-p53 Pathway
{{output}}
Advanced breast cancer, especially advanced triple-negative breast cancer, is typically more aggressive and more difficult to treat than other breast cancer phenotypes. There is currently no curable option for breast cancer patients with advanced diseases, hig... ...